- Home
- AKRO vs BANF Comparison
AKRO vs BANF Comparison
Compare AKRO & BANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- BANF
- Stock Information
- Founded
- AKRO 2017
- BANF 1984
- Country
- AKRO United States
- BANF United States
- Employees
- AKRO N/A
- BANF N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- BANF Major Banks
- Sector
- AKRO Health Care
- BANF Finance
- Exchange
- AKRO Nasdaq
- BANF Nasdaq
- Market Cap
- AKRO 3.6B
- BANF 4.2B
- IPO Year
- AKRO 2019
- BANF N/A
- Fundamental
- Price
- AKRO $46.27
- BANF $134.47
- Analyst Decision
- AKRO Strong Buy
- BANF Hold
- Analyst Count
- AKRO 8
- BANF 2
- Target Price
- AKRO $80.38
- BANF $134.00
- AVG Volume (30 Days)
- AKRO 915.6K
- BANF 108.3K
- Earning Date
- AKRO 11-07-2025
- BANF 10-16-2025
- Dividend Yield
- AKRO N/A
- BANF 1.43%
- EPS Growth
- AKRO N/A
- BANF 15.84
- EPS
- AKRO N/A
- BANF 6.94
- Revenue
- AKRO N/A
- BANF $656,148,000.00
- Revenue This Year
- AKRO N/A
- BANF $12.29
- Revenue Next Year
- AKRO N/A
- BANF $4.01
- P/E Ratio
- AKRO N/A
- BANF $18.59
- Revenue Growth
- AKRO N/A
- BANF 10.44
- 52 Week Low
- AKRO $21.34
- BANF $97.02
- 52 Week High
- AKRO $58.40
- BANF $138.77
- Technical
- Relative Strength Index (RSI)
- AKRO 51.29
- BANF 57.59
- Support Level
- AKRO $41.80
- BANF $128.89
- Resistance Level
- AKRO $45.44
- BANF $135.05
- Average True Range (ATR)
- AKRO 1.97
- BANF 2.77
- MACD
- AKRO 0.06
- BANF -0.41
- Stochastic Oscillator
- AKRO 75.76
- BANF 57.59
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About BANF BancFirst Corporation
BancFirst Corp is engaged in providing banking services. The company's business unit includes BancFirst metropolitan banks, BancFirst community banks, Pegasus Bank, Worthington, other financial services and executive, operations and support. BancFirst metropolitan banks, BancFirst community banks, Pegasus and Worthington offer traditional banking products such as commercial and retail lending and a full line of deposit accounts. Other financial services are specialty product business units including guaranteed small business lending, residential mortgage lending, trust services, securities brokerage, electronic banking, and insurance.